Average Co-Inventor Count = 2.34
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The Cleveland Clinic Foundation (27 from 1,036 patents)
2. University of Illinois (23 from 2,340 patents)
3. Cleveland Biolabs, Inc. (14 from 16 patents)
4. Incuron, LLC (6 from 8 patents)
5. Genome Protection, Inc. (4 from 7 patents)
6. Health Research, Inc. (3 from 310 patents)
7. Other (2 from 832,680 patents)
8. University Technologies International, Inc. (2 from 113 patents)
9. Panacela Labs, Inc. (2 from 3 patents)
10. Children's Cancer Institute Australia for Medical Research (2 from 2 patents)
11. Ariel Scientific Innovations Ltd. (1 from 48 patents)
12. University of Il (1 from 3 patents)
13. Roswell Park Cancer Institute (2 patents)
72 patents:
1. 12115207 - Treatment of inflammation
2. 11628201 - Use of toll-like receptor agonist for treating cancer
3. 11542306 - Flagellin-based agents and uses including effective vaccination
4. 11235028 - Protection against stress-mediated damage from ionizing radiation
5. 10975127 - Flagellin-based agents and uses including effective vaccination
6. 10898543 - Flagellin related polypeptides and uses thereof
7. 10780152 - Use of toll-like receptor agonist for treating cancer
8. 10730915 - Flagellin-based agents and uses including effective vaccination
9. 10543251 - Flagellin related polypeptides and uses thereof
10. 10406206 - Protection against stress-mediated damage from ionizing radiation
11. 10336793 - Flagellin-based agents and uses including effective vaccination
12. 10265390 - Use of toll-like receptor agonist for treating cancer
13. 10137109 - Carbazole compounds and therapeutic uses of the compounds
14. 10086038 - Flagellin related polypeptides and uses thereof
15. 10034926 - Use of toll-like receptor agonist for treating cancer